Buscar
-
HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries
(PLoS medicine. vol. 15, n° 3, pp. e1002534, 2018-03)Article de revueLibre acceso -
Measuring retention in care for HIV-positive pregnant women in Prevention of Mother-to-Child Transmission of HIV (PMTCT) option B+ programs: the Mozambique experience
(BMC public health. vol. 20, n° 1, pp. 322, 2020)Article de revueLibre acceso -
"If you are here at the clinic, you do not know how many people need help in the community": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat
(PLoS ONE. vol. 13, n° 11, pp. e0202473, 2018-11-10)Article de revueLibre acceso -
Retention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial)
(Journal of acquired immune deficiency syndromes (1999). vol. 80, n° 4, pp. 375-385, 2019-04-01)Article de revueLibre acceso -
Integrating Electronic Patient-Reported Outcome Measures into Routine HIV Care and the ANRS CO3 Aquitaine Cohort's Data Capture and Visualization System (QuAliV): Protocol for a Formative Research Study
(JMIR Research Protocols. vol. 7, n° 6, pp. e147, 2018-06-07)Article de revueLibre acceso -
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
(Journal of the International AIDS Society. vol. 23, n° 2, pp. e25455, 2020)Article de revueLibre acceso -
The Global Fund in the era of SDGs: time to rethink?
(The Lancet Public Health. vol. 5, n° 1, pp. e17, 2020)Article de revueLibre acceso -
The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa)
(Journal of the International AIDS Society. vol. 21, n° Suppl 4, pp. e25128, 2018-07)Article de revueLibre acceso -
Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa
(Journal of the International AIDS Society. vol. 22, n° 10, pp. e25402, 2019-10)Article de revueLibre acceso -
Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART
(J Antimicrob Chemother. vol. 74, n° 2, pp. 473-479, 2019-02-01)Article de revueLibre acceso